157 related articles for article (PubMed ID: 1919745)
1. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.
Stewart RE; Heyl B; O'Rourke RA; Blumhardt R; Miller DD
J Nucl Med; 1991 Oct; 32(10):2000-8. PubMed ID: 1919745
[TBL] [Abstract][Full Text] [Related]
2. Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Cardiol; 1994; 1(4):338-50. PubMed ID: 9420717
[TBL] [Abstract][Full Text] [Related]
3. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
[TBL] [Abstract][Full Text] [Related]
4. Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole: differentiation of stenosis severity in canine myocardium.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Med; 1995 Jan; 36(1):111-9. PubMed ID: 7799062
[TBL] [Abstract][Full Text] [Related]
5. Early myocardial clearance kinetics of technetium-99m-teboroxime differentiate normal and flow-restricted canine myocardium at rest.
Johnson G; Glover DK; Hebert CB; Okada RD
J Nucl Med; 1993 Apr; 34(4):630-6. PubMed ID: 8455080
[TBL] [Abstract][Full Text] [Related]
6. Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera.
Chua T; Kiat H; Germano G; Takemoto K; Fernandez G; Biasio Y; Friedman J; Berman D
J Nucl Med; 1993 Sep; 34(9):1485-93. PubMed ID: 8355068
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
Gray WA; Gewirtz H
Circulation; 1991 Oct; 84(4):1796-807. PubMed ID: 1914115
[TBL] [Abstract][Full Text] [Related]
8. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs.
Pieri P; Yasuda T; Fischman AJ; Ahmad M; Moore R; Yaoita H; Strauss HW
Eur J Nucl Med; 1991; 18(9):725-31. PubMed ID: 1936048
[TBL] [Abstract][Full Text] [Related]
9. Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole injection.
Gewirtz H
J Nucl Med; 1995 Jan; 36(1):119-20. PubMed ID: 7799063
[No Abstract] [Full Text] [Related]
10. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
[TBL] [Abstract][Full Text] [Related]
11. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1991 Oct; 32(10):1968-76. PubMed ID: 1919740
[TBL] [Abstract][Full Text] [Related]
12. Planar myocardial perfusion imaging with technetium-99m-teboroxime: comparison by vascular territory with thallium-201 and coronary angiography.
Dahlberg ST; Weinstein H; Hendel RC; McSherry B; Leppo JA
J Nucl Med; 1992 Oct; 33(10):1783-8. PubMed ID: 1403145
[TBL] [Abstract][Full Text] [Related]
13. Detection of coronary artery disease by dynamic planar and single photon emission tomographic imaging with technetium-99m teboroxime.
Yamagami H; Ishida Y; Morozumi T; Kozuka T; Nishimura T
Eur J Nucl Med; 1994 Jan; 21(1):27-36. PubMed ID: 8088283
[TBL] [Abstract][Full Text] [Related]
14. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
[TBL] [Abstract][Full Text] [Related]
15. Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.
Smith AM; Gullberg GT; Christian PE
J Nucl Cardiol; 1996; 3(2):130-42. PubMed ID: 8799238
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease.
Chua T; Kiat H; Germano G; Palmas W; Takemoto K; Friedman J; Berman DS
Am J Cardiol; 1993 Sep; 72(9):728-34. PubMed ID: 8249853
[TBL] [Abstract][Full Text] [Related]
17. Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.
Stewart RE; Schwaiger M; Hutchins GD; Chiao PC; Gallagher KP; Nguyen N; Petry NA; Rogers WL
J Nucl Med; 1990 Jul; 31(7):1183-90. PubMed ID: 2362197
[TBL] [Abstract][Full Text] [Related]
18. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility.
Bisi G; Sciagrà R; Santoro GM; Zerauschek F; Fazzini PF
J Nucl Med; 1994 Aug; 35(8):1274-8. PubMed ID: 8046478
[TBL] [Abstract][Full Text] [Related]
19. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
Iskandrian AS; Heo J; Nguyen T; Beer S; Cave V; Cassel D; Iskandrian BB
J Am Coll Cardiol; 1992 Feb; 19(2):307-12. PubMed ID: 1732357
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
